ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Monsanto appears to be taking itself out of agriculture chemical deal contention. In a conference call with analysts, CEO Hugh Grant said he no longer sees “large-scale M&A as a likely opportunity.” Last year, Syngenta rebuffed a $45 billion acquisition bid from Monsanto, agreeing instead to a $43 billion offer from ChemChina. Consolidation in the agricultural chemical and seed business helped influence the pending merger of Dow Chemical and DuPont. Speculation that Bayer, BASF, and Monsanto might look to transactions has persisted for months. “Our strategy is innovation-driven, and it’s highly collaborative,” Grant said. The company has a crop-traits collaboration with BASF.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X